Conference program
The AFPS 2025 Conference offers a dynamic three-day program designed to maximise learning and networking opportunities.
Each day will begin with thought-provoking keynote presentations from leaders in pharmaceutical science, followed by concurrent sessions of oral presentations, panel discussions and debate, workshops, and innovation showcases. The program will feature expert-led panel discussions on critical topics including digital therapeutics, bio convergence and sustainable pharmaceutical practices.
Interactive workshops and masterclasses will provide hands-on experience with cutting-edge laboratory techniques and professional development training.
Throughout the conference, dedicated poster sessions will showcase emerging research, while the innovation hub will host live demonstrations of breakthrough technologies. Networking sessions are strategically scheduled to facilitate meaningful connections among attendees.
A detailed program schedule, including confirmed speakers and session times, will be released in mid-2025 with the content focused on the following themes:
Conference themes
- Advances in genomics, gene editing, and precision medicine.
- Ethical/legal considerations and regulatory challenges.
- Advancements in in vitro models, organoids, and computational simulations.
- 3Rs and cruelty-free research and development.
- Advances in 3D technology for personalised medicines
- Regulatory considerations, quality control, clinician and patient acceptance
- Inaugural forum for an Asian Paediatric Formulation Initiative
- Development and evaluation of age-appropriate paediatric formulations
- Taste-masking strategies for paediatric formulations
- AI for drug discovery, drug formulation, patient care, and supply chain optimisation.
- Medicine without Meds – transforming patient care with digital therapies
- Ethical implications and data privacy.
- Extracellular vesicles as drug delivery vectors and adjuvants.
- Nanotechnology applications in drug formulation and targeted delivery.
- Safety, efficacy, and scalability.
- The next generation antibiotics and bacteriophage-based strategies to AMR.
- Pharmaceutical and biotechnological solutions to AMR.
- AMR in the public health context.
- Evidence-based herbal medicine, traditional practices, and holistic approaches – indigenous medicines.
- Synergies with pharmaceuticals.
- Autonomous labs for sample processing, quality control, and inventory management.
- Safety protocols and cost-effectiveness.
- Mechanopharmacology in drug discovery.
- Mechanobiology as a biomarker in drug development and testing.
- Collaboration between pharmaceutical companies and research institutions.
- Success stories and best practices.
- Hospital drug management, patient safety, and clinical pharmacy.
- Interdisciplinary teamwork.